Column GROUP L P, Director, 10% Owner, Ten Percent Owner Other at NGM BIOPHARMACEUTICALS INC (NGM), bought 36,790 shares at $17.97 ($661K) on 2020-08-21, disclosed to the SEC on 2020-08-25.
Open-market purchase of $661k NGM by Director, 10% Owner, Ten Percent Owner Other. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.97 | 7,321 | $132K | 19.9% |
| 2 | $17.97 | 7,321 | $132K | 19.9% |
| 3 | $17.96 | 11,024 | $198K | 30.0% |
| 4 | $17.96 | 11,024 | $198K | 30.0% |
| 5 | $18.00 | 100 | $2K | 0.3% |
| Total | $17.96 avg | 36,790 |
| $661K |
| 100% |
| Filing → |
| NGM | BUY | 2023-01-12 | $2.0M | — | Filing → |
| NGM | BUY | 2022-11-07 | $1.4M | — | Filing → |
| NGM | BUY | 2022-10-31 | $747K | — | Filing → |